T1	Participants 441 534	Sixty-eight patients with prominent nasolabial folds were randomized to intradermal treatment
T2	Participants 713 721	patients
T3	Participants 753 787	bilateral retreatment with Perlane
T4	Participants 926 939	patient-based
T5	Participants 903 921	Investigator-based
T6	Participants 1204 1213	patients,
T7	Participants 1293 1302	patients,
T8	Participants 1535 1543	patients
